Search - tctmd.com

Displaying 661 - 680 of 681

Sort: Relevancy | Date

News Daily News

‘Value’ of PCI Varies Widely Across VA Hospitals

Yael L. Maxwell

January 28, 2015

News Features

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Yael L. Maxwell

June 27, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Yael L. Maxwell

July 10, 2012

News Daily News

Hospital Readmission After PCI ‘High’

March 06, 2012

News Daily News

Comprehensive Exercise Therapy Program Motivates Physical Activity Post-PCI

Yael L. Maxwell

January 23, 2012

News Conference News

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

November 16, 2011

News Daily News

Selective Use of DES Saves Millions of Dollars a Year

Jason Kahn

August 15, 2011

News Daily News

Study Finds All-Comers Design Not So All Inclusive

Caitlin E. Cox

June 15, 2011

News Daily News

DES Add Over $1.5 Billion in Medicare Costs to Health Care System

Jason Kahn

April 28, 2011

News Daily News

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

February 15, 2011

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

The Educational Awareness of the diagnosis of patients with DMR & FMR

Improving TAVR Outcomes Duirng COVID-19: The Role Virtual Proctoring & CME

CME

Improving TAVR Outcomes During COVID-19: The Role Virtual Proctoring & CME

CME

Advertisement

‘Value’ of PCI Varies Widely Across VA Hospitals

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Innovation in Intervention: Perspectives from Industry

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Hospital Readmission After PCI ‘High’

Comprehensive Exercise Therapy Program Motivates Physical Activity Post-PCI

‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year

Selective Use of DES Saves Millions of Dollars a Year

Study Finds All-Comers Design Not So All Inclusive

DES Add Over $1.5 Billion in Medicare Costs to Health Care System

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

The Educational Awareness of the diagnosis of patients with DMR & FMR

Improving TAVR Outcomes During COVID-19: The Role Virtual Proctoring & CME

TAVR: Economics & Efficiencies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content